NEW YORK--(BUSINESS WIRE)--
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Omega Protein Corporation (NYSE:OME). Our investigation concerns whether Omega and certain of its officers and/or directors have violated federal securities laws and/or engaged in other unlawful business practices.
On March 1, 2017, the Company disclosed that it had received a subpoena from the SEC, requesting information in connection to an investigation of an Omega subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees.
Following this news, Omega Protein shares fell $6.25 per share, or approximately 23.8%, to close at $20.00 per share on March 2, 2017.
If you purchased or otherwise acquired Omega Protein securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact J. Brandon Walker, Esq. by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Omega Protein, please go to www.bespc.com/omegaprotein. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170302006386/en/
